<?xml version="1.0" encoding="UTF-8"?>
<p id="p0230">The research and development of a significant number of nucleos(t)ide analogues were terminated in the preclinical assay stage due to the toxicity they induced in animal models. High toxicity was also the reason for the rejection of many compounds during clinical trials. Examples of nucleos(t)ide-based analogues that exhibit high activity against herpesviruses but were not approved as drugs are shown in 
 <xref rid="fig5" ref-type="fig">Fig. 5</xref> and are described below.
</p>
